Popular Articles

Heparin Use Prior To Endoscopic Vein Harvest Improves Graft Patency In Off-Pump Coronary Artery Bypass Patients
MAQUET Cardiovascular LLC announced that data presented at the annual meeting of the International Society for Minimally Invasive Cardiothoracic Surgery show that administration of a heparin bolus with doses as low as 2500U prior to endoscopic vein harvest (EVH) was associated with improved acute saphenous vein (SV) graft patency in patients undergoing off-pump coronary artery bypass (OPCAB). Pre-heparinization was also linked to a significant reduction in the incidence and volume of residual clot strands within the vein.

Deep Vein Thrombosis: The Risk During A Flight Is Often Overestimated
The risk of developing deep vein thrombosis during a long flight is often overestimated. According to the German Institute for Quality and Efficiency in Health Care (IQWiG), this condition is very unlikely in healthy travellers. When people wear a cast or splint after a sports accident, on the other hand, many are not aware that they have an increased risk of deep vein thrombosis in their leg and pelvic area. This is emphasised in information published on IQWiG"s website Informed Health Online.
News of the day
Human Trials Commence Next Year For The First Genetically-Engineered Malaria Vaccine
Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease. The vaccine, developed in collaboration with researchers from the US, Japan and Canada, will be trialled in humans from early next year.
Nutrition

Senate Passes Family Smoking Prevention And Tobacco Control Act - FDA To Have Unprecedented Powers To Regulate Tobacco

In a move that will fundamentally redefine the way the United States regulates tobacco, today the Senate passed the Family Smoking Prevention and Tobacco Control Act (H.R. 1256) by a vote of 79 to 17. This legislation grants the Food and Drug Administration (FDA) authority to regulate the marketing of tobacco products, specifically marketing designed to mislead consumers or recruit underage smokers. "It is time that attention is drawn to the long time, intentional targeting of children by the tobacco industry," said John Heffner, M.D., past president of the ATS. "We have too long tolerated the industry"s efforts to cultivate smokers at a young and vulnerable age to guarantee profit for tobacco producers." The Family Smoking Prevention and Tobacco Control Act grants the FDA the tools to combat these practices in the tobacco industry and will immediately reduce the ability of tobacco companies to recruit new smokers and limit the devastation caused by tobacco-related disease. "Throughout my career, I have treated many hundreds of patients who have been devastated by illnesses caused by and related to tobacco addiction. I have also watched countless family members suffer as a result of these illnesses," said ATS president, J. Randall Curtis, M.D. "This legislation offers us an unprecedented opportunity to stop tobacco addiction before it starts by allowing the FDA to ensure that tobacco products are not marketed to children and that the tobacco industry is required to advertise these products honestly." The legislation specifically gives the FDA the authority to: - Crack down on tobacco marketing and sales to children. - Ban candy-flavored cigarettes - Require disclosure of the contents of tobacco products. - Compel the tobacco industry to research about the health effects of their products. - Mandate changes in tobacco products such as the removal of harmful ingredients. - Prohibit terms such as "light", "mild" and "low-tar" that mislead consumers into believing that certain cigarettes are safer than others. - Stop marketing claims that may discourage current tobacco users from quitting or persuade potential users to start. - Require larger, more effective health warnings on tobacco products. The House of Representatives passed this legislation by a vote of 298-112 earlier this year. The legislation will now to go to a conference committee between the House and Senate to resolve the minor differences between the House and Senate versions. President Obama supports the legislation and has pledged to sign it. Enacting legislation to give the FDA authority to regulate tobacco products has been a goal of the ATS since the idea was proposed a decade ago. The Society"s interest in regulating tobacco is longer-standing. The ATS and research published in its journals were cited extensively in the 1964 report Smoking and Health: Report of the Advisory Committee to the Surgeon General, which warned that "cigarette smoking is a health hazard of sufficient importance in the United States to warrant appropriate remedial action." Now, 45 years later, legislation has finally been enacted to bring about that appropriate remedial action. ATS members have been passionate in the support for enacting this legislation and have testified before Congress about the ills of smoking and the need for effective regulation of tobacco products. The ATS has been a vocal supporter of the bill and has featured the FDA tobacco bill on several advocacy days and visits with members of Congress. The ATS believes that enactment of the FDA tobacco bill is the most effective way to reduce tobacco use in the U.S. and to improve respiratory health. American Thoracic Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):